Inventor

Antonio Guglietta

Inventor
Barcelona, ES

Overview

25→
Patents
1995–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds24%
C07CAcyclic or carbocyclic compounds5%
C07KPeptides2%
PatentTitleYear
10,072,000Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines201810,022,363Pharmaceutical topical compositions20189,399,014'Pharmaceutical topical compositions'20169,180,200'Pharmaceutical topical compositions'20158,993,562'Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions'20158,530,482'Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates'20138,354,430'Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine'20138,338,436'Amorphous form of N-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide'20128,273,753'Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide'20128,227,501'1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds'20128,207,197'Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine'20128,158,632'Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions'20128,153,789'Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions'20128,039,476'Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide'20118,008,486'Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound'20117,947,688'N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto'20117,943,611'Imidazo[1,2-A]pyridin-3-yl-acetic acid hydrazides, processes, for their preparation and pharmaceutical uses thereof'20117,759,351'Oxazolidinone compounds, and compositions and methods related thereto'20107,470,814'Process for the preparation of substituted 7-allyl-6-hydroxy-indanes'20087,323,433'R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole'20086,426,368'Method for preventing and treating alcoholism'20026,242,488'Method for preventing and treating pain'20016,127,418'GABA analogs to prevent and treat gastrointestinal damage'20006,028,095'Treatment of inflammatory bowel disease using histamine H.sub.3 -receptor agonists'20005,434,135'Growth factor compositions, preparation and use'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2002Based in Ann Arbor, MI, US· patent location history
2000–2002Patents assigned to WARNER LAMBERT CO (4)· patent assignee history
2008–2018Patents assigned to FERRER INT (18)· patent assignee history
2008–2018Based in Barcelona, ES· patent location history
2008Based in San Joan d'Alacant, ES· patent location history
2011–2018Based in Molins de Rei, ES· patent location history
2012–2015Patents assigned to GUGLIETTA ANTONIO (10)· patent assignee history
2012–2015Patents assigned to PALOMER ALBERT (7)· patent assignee history
2012–2013Patents assigned to ANGLADA LUIS (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
FERRER INT182008–2018
GUGLIETTA ANTONIOself102012–2015
PALOMER ALBERT72012–2015
ANGLADA LUIS42012–2013
WARNER LAMBERT CO42000–2002
Locations
LocationPatentsSpan
Barcelona, ES122008–2018
Molins de Rei, ES72011–2018
Ann Arbor, MI, US51995–2002
San Joan d'Alacant, ES12008